Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer.
Highlights
The global Uterine Fibroid Treatment Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Uterine Fibroid Treatment Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Uterine Fibroid Treatment Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Uterine Fibroid Treatment Device in Invasive Treatment is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Uterine Fibroid Treatment Device include Medtronic, Stryker Corporation, Boston Scientific Corporation, INSIGHTEC, CooperSurgical Inc., Hologic, Inc., Lumenis, Gynesonics and Chongqing Haifu Medical Technology, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Uterine Fibroid Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Fibroid Treatment Device.
The Uterine Fibroid Treatment Device market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Uterine Fibroid Treatment Device market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Uterine Fibroid Treatment Device companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Stryker Corporation
Boston Scientific Corporation
INSIGHTEC
CooperSurgical Inc.
Hologic, Inc.
Lumenis
Gynesonics
Chongqing Haifu Medical Technology
Shenzhen PRO HITU Medical
Segment by Type
Surgical Techniques
Laparoscopic Techniques
Ablation Techniques
Embolization Technique
Segment by Application
Invasive Treatment
Minimally Invasive Treatment
Non-invasive Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Uterine Fibroid Treatment Device companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Fibroid Treatment Device Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Surgical Techniques
1.2.3 Laparoscopic Techniques
1.2.4 Ablation Techniques
1.2.5 Embolization Technique
1.3 Market by Application
1.3.1 Global Uterine Fibroid Treatment Device Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Invasive Treatment
1.3.3 Minimally Invasive Treatment
1.3.4 Non-invasive Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Uterine Fibroid Treatment Device Market Perspective (2018-2029)
2.2 Uterine Fibroid Treatment Device Growth Trends by Region
2.2.1 Global Uterine Fibroid Treatment Device Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Uterine Fibroid Treatment Device Historic Market Size by Region (2018-2023)
2.2.3 Uterine Fibroid Treatment Device Forecasted Market Size by Region (2024-2029)
2.3 Uterine Fibroid Treatment Device Market Dynamics
2.3.1 Uterine Fibroid Treatment Device Industry Trends
2.3.2 Uterine Fibroid Treatment Device Market Drivers
2.3.3 Uterine Fibroid Treatment Device Market Challenges
2.3.4 Uterine Fibroid Treatment Device Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Uterine Fibroid Treatment Device Players by Revenue
3.1.1 Global Top Uterine Fibroid Treatment Device Players by Revenue (2018-2023)
3.1.2 Global Uterine Fibroid Treatment Device Revenue Market Share by Players (2018-2023)
3.2 Global Uterine Fibroid Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroid Treatment Device Revenue
3.4 Global Uterine Fibroid Treatment Device Market Concentration Ratio
3.4.1 Global Uterine Fibroid Treatment Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroid Treatment Device Revenue in 2022
3.5 Uterine Fibroid Treatment Device Key Players Head office and Area Served
3.6 Key Players Uterine Fibroid Treatment Device Product Solution and Service
3.7 Date of Enter into Uterine Fibroid Treatment Device Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Uterine Fibroid Treatment Device Breakdown Data by Type
4.1 Global Uterine Fibroid Treatment Device Historic Market Size by Type (2018-2023)
4.2 Global Uterine Fibroid Treatment Device Forecasted Market Size by Type (2024-2029)
5 Uterine Fibroid Treatment Device Breakdown Data by Application
5.1 Global Uterine Fibroid Treatment Device Historic Market Size by Application (2018-2023)
5.2 Global Uterine Fibroid Treatment Device Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Uterine Fibroid Treatment Device Market Size (2018-2029)
6.2 North America Uterine Fibroid Treatment Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Uterine Fibroid Treatment Device Market Size by Country (2018-2023)
6.4 North America Uterine Fibroid Treatment Device Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Uterine Fibroid Treatment Device Market Size (2018-2029)
7.2 Europe Uterine Fibroid Treatment Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Uterine Fibroid Treatment Device Market Size by Country (2018-2023)
7.4 Europe Uterine Fibroid Treatment Device Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Uterine Fibroid Treatment Device Market Size (2018-2029)
8.2 Asia-Pacific Uterine Fibroid Treatment Device Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Uterine Fibroid Treatment Device Market Size by Region (2018-2023)
8.4 Asia-Pacific Uterine Fibroid Treatment Device Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Uterine Fibroid Treatment Device Market Size (2018-2029)
9.2 Latin America Uterine Fibroid Treatment Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Uterine Fibroid Treatment Device Market Size by Country (2018-2023)
9.4 Latin America Uterine Fibroid Treatment Device Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Uterine Fibroid Treatment Device Market Size (2018-2029)
10.2 Middle East & Africa Uterine Fibroid Treatment Device Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Uterine Fibroid Treatment Device Market Size by Country (2018-2023)
10.4 Middle East & Africa Uterine Fibroid Treatment Device Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Uterine Fibroid Treatment Device Introduction
11.1.4 Medtronic Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Detail
11.2.2 Stryker Corporation Business Overview
11.2.3 Stryker Corporation Uterine Fibroid Treatment Device Introduction
11.2.4 Stryker Corporation Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.2.5 Stryker Corporation Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Uterine Fibroid Treatment Device Introduction
11.3.4 Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.3.5 Boston Scientific Corporation Recent Development
11.4 INSIGHTEC
11.4.1 INSIGHTEC Company Detail
11.4.2 INSIGHTEC Business Overview
11.4.3 INSIGHTEC Uterine Fibroid Treatment Device Introduction
11.4.4 INSIGHTEC Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.4.5 INSIGHTEC Recent Development
11.5 CooperSurgical Inc.
11.5.1 CooperSurgical Inc. Company Detail
11.5.2 CooperSurgical Inc. Business Overview
11.5.3 CooperSurgical Inc. Uterine Fibroid Treatment Device Introduction
11.5.4 CooperSurgical Inc. Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.5.5 CooperSurgical Inc. Recent Development
11.6 Hologic, Inc.
11.6.1 Hologic, Inc. Company Detail
11.6.2 Hologic, Inc. Business Overview
11.6.3 Hologic, Inc. Uterine Fibroid Treatment Device Introduction
11.6.4 Hologic, Inc. Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.6.5 Hologic, Inc. Recent Development
11.7 Lumenis
11.7.1 Lumenis Company Detail
11.7.2 Lumenis Business Overview
11.7.3 Lumenis Uterine Fibroid Treatment Device Introduction
11.7.4 Lumenis Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.7.5 Lumenis Recent Development
11.8 Gynesonics
11.8.1 Gynesonics Company Detail
11.8.2 Gynesonics Business Overview
11.8.3 Gynesonics Uterine Fibroid Treatment Device Introduction
11.8.4 Gynesonics Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.8.5 Gynesonics Recent Development
11.9 Chongqing Haifu Medical Technology
11.9.1 Chongqing Haifu Medical Technology Company Detail
11.9.2 Chongqing Haifu Medical Technology Business Overview
11.9.3 Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Introduction
11.9.4 Chongqing Haifu Medical Technology Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.9.5 Chongqing Haifu Medical Technology Recent Development
11.10 Shenzhen PRO HITU Medical
11.10.1 Shenzhen PRO HITU Medical Company Detail
11.10.2 Shenzhen PRO HITU Medical Business Overview
11.10.3 Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Introduction
11.10.4 Shenzhen PRO HITU Medical Revenue in Uterine Fibroid Treatment Device Business (2018-2023)
11.10.5 Shenzhen PRO HITU Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
Stryker Corporation
Boston Scientific Corporation
INSIGHTEC
CooperSurgical Inc.
Hologic, Inc.
Lumenis
Gynesonics
Chongqing Haifu Medical Technology
Shenzhen PRO HITU Medical
*If Applicable.